485 related articles for article (PubMed ID: 11965534)
41. Mutations of the p53 gene and loss of heterozygosity at chromosome 17p13.1 are associated with increased survivin expression in breast cancer.
Tsuji N; Furuse K; Asanuma K; Furuya M; Kondoh K; Kamagata C; Sasaki M; Kobayashi D; Yagihashi A; Takahashi H; Watanabe N
Breast Cancer Res Treat; 2004 Sep; 87(1):23-31. PubMed ID: 15377848
[TBL] [Abstract][Full Text] [Related]
42. Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells.
Moriai R; Asanuma K; Kobayashi D; Yajima T; Yagihashi A; Yamada M; Watanabe N
Anticancer Res; 2001; 21(1B):595-600. PubMed ID: 11299811
[TBL] [Abstract][Full Text] [Related]
43. Mitosis-independent survivin gene expression in vivo and regulation by p53.
Xia F; Altieri DC
Cancer Res; 2006 Apr; 66(7):3392-5. PubMed ID: 16585159
[TBL] [Abstract][Full Text] [Related]
44. p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction.
Zhang D; Cao D; Russell R; Pizzorno G
Cancer Res; 2001 Sep; 61(18):6899-905. PubMed ID: 11559567
[TBL] [Abstract][Full Text] [Related]
45. Human smooth muscle alpha-actin gene is a transcriptional target of the p53 tumor suppressor protein.
Comer KA; Dennis PA; Armstrong L; Catino JJ; Kastan MB; Kumar CC
Oncogene; 1998 Mar; 16(10):1299-308. PubMed ID: 9546431
[TBL] [Abstract][Full Text] [Related]
46. Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin.
Yonesaka K; Tamura K; Kurata T; Satoh T; Ikeda M; Fukuoka M; Nakagawa K
Int J Cancer; 2006 Feb; 118(4):812-20. PubMed ID: 16108013
[TBL] [Abstract][Full Text] [Related]
47. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.
Driouch K; Prydz H; Monese R; Johansen H; Lidereau R; Frengen E
Oncogene; 2002 Mar; 21(12):1832-40. PubMed ID: 11896615
[TBL] [Abstract][Full Text] [Related]
48. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
49. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
50. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.
Krieg A; Mahotka C; Krieg T; Grabsch H; Müller W; Takeno S; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
Br J Cancer; 2002 Mar; 86(5):737-43. PubMed ID: 11875736
[TBL] [Abstract][Full Text] [Related]
51. Mitofusin-2 is a novel direct target of p53.
Wang W; Cheng X; Lu J; Wei J; Fu G; Zhu F; Jia C; Zhou L; Xie H; Zheng S
Biochem Biophys Res Commun; 2010 Oct; 400(4):587-92. PubMed ID: 20804729
[TBL] [Abstract][Full Text] [Related]
52. Epothilone B induces glioblastoma cell death via survivin down-regulation.
Quick QA
Exp Oncol; 2008 Sep; 30(3):195-201. PubMed ID: 18806741
[TBL] [Abstract][Full Text] [Related]
53. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system.
Okamura S; Ng CC; Koyama K; Takei Y; Arakawa H; Monden M; Nakamura Y
Oncol Res; 1999; 11(6):281-5. PubMed ID: 10691030
[TBL] [Abstract][Full Text] [Related]
54. Sp1 upregulates survivin expression in adenocarcinoma of lung cell line A549.
Chen Y; Wang X; Li W; Zhang H; Zhao C; Li Y; Wang Z; Chen C
Anat Rec (Hoboken); 2011 May; 294(5):774-80. PubMed ID: 21433308
[TBL] [Abstract][Full Text] [Related]
55. Regulation of BRCA1 and BRCA2 transcript in response to cisplatin, adriamycin, taxol and ionising radiation is correlated to p53 functional status in ovarian cancer cell lines.
Aunoble B; Bernard-Gallon D; Bignon YJ
Oncol Rep; 2001; 8(3):663-8. PubMed ID: 11295099
[TBL] [Abstract][Full Text] [Related]
56. Activation of cancer-specific gene expression by the survivin promoter.
Bao R; Connolly DC; Murphy M; Green J; Weinstein JK; Pisarcik DA; Hamilton TC
J Natl Cancer Inst; 2002 Apr; 94(7):522-8. PubMed ID: 11929953
[TBL] [Abstract][Full Text] [Related]
57. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer.
Zhang T; Otevrel T; Gao Z; Gao Z; Ehrlich SM; Fields JZ; Boman BM
Cancer Res; 2001 Dec; 61(24):8664-7. PubMed ID: 11751382
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53.
Loging WT; Reisman D
Oncogene; 1999 Dec; 18(52):7608-15. PubMed ID: 10602522
[TBL] [Abstract][Full Text] [Related]
59. Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line.
Chang E; Donahue J; Smith A; Hornick J; Rao JN; Wang JY; Battafarano RJ
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):225-32. PubMed ID: 20236666
[TBL] [Abstract][Full Text] [Related]
60. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
